Literature DB >> 32377767

Red cell alloimmunisation in patients receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO).

Deepa R J Arachchillage1,2,3, Steve Owen4, Maria Anievas4, Mihaela Gaspar4, Mike Laffan5,6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32377767     DOI： 10.1007/s00134-020-06051-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  1 in total

1.  Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study.

Authors:  Deepa J Arachchillage; Indika Rajakaruna; Ian Scott; Mihaela Gaspar; Zain Odho; Winston Banya; Aikaterini Vlachou; Graziella Isgro; Lenka Cagova; Joshua Wade; Lucy Fleming; Mike Laffan; Richard Szydlo; Stephane Ledot; Rachel Jooste; Alain Vuylsteke; Hakeem Yusuff
Journal:  Br J Haematol       Date:  2021-10-07       Impact factor: 8.615
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.